Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoids and an Anti-inflammatory Diet for the Treatment of Neuropathic Pain After Spinal Cord Injury
NCT04057456Phase 3Completed
- Start
- Mar 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nabilone in neuropathic pain. Started Mar 2023; status: completed.
02
Drugs
nabilone
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT04057456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04057456.